


Healthcare News Roundup: Neurology
HSMN NewsFeed - 28 Jan 2013
BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer
BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer
HSMN NewsFeed - 28 Jan 2013
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
HSMN NewsFeed - 14 Jan 2013
Covidien Opens Patient Enrollment for SWIFT PRIME Acute Ischemic Stroke Study
Covidien Opens Patient Enrollment for SWIFT PRIME Acute Ischemic Stroke Study
HSMN NewsFeed - 9 Jan 2013
Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies
Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies
HSMN NewsFeed - 7 Jan 2013
RusnanoMedInvest and Domain Associates Invest In Neurology Company Marinus Pharmaceuticals
RusnanoMedInvest and Domain Associates Invest In Neurology Company Marinus Pharmaceuticals
HSMN NewsFeed - 18 Dec 2012
FDA Clears IND For First Clinical Trial Protocol Developed Using Crowdsourcing
FDA Clears IND For First Clinical Trial Protocol Developed Using Crowdsourcing
HSMN NewsFeed - 17 Dec 2012
CAS Medical Systems Names Dr. John Gamelin as Vice President of Research & Development
CAS Medical Systems Names Dr. John Gamelin as Vice President of Research & Development
HSMN NewsFeed - 13 Dec 2012
Covidien’s Solitaire(TM) FR Revascularization Device Receives Regulatory Approval in Canada
Covidien’s Solitaire(TM) FR Revascularization Device Receives Regulatory Approval in Canada
